ezetimibe数据资料的不足暴露了药品审批制度的一个方面，即使是精明的病人可能都弄不明白。
The lack of data about ezetimibe highlights an aspect of the drug approval system that even sophisticated patients may not understand.
采购资料须经供应部负责人审批，方可实施，采购员使用采购资料时，应认真审核。
Purchasing data should approved by supplier responsible person, and implement, the buyer should audit carefully when use purchasing data.
FDA审批程序的好处之一是需要生产商提供有关如何安全处方和使用药品的完整资料。
One benefit of the FDA approval process is a requirement for manufacturers to provide sufficient information on how to safely prescribe and use a drug.
应用推荐